Antithrombotic treatment in ischemic cerebrovascular disease

Intern Med. 1998 Feb;37(2):197-9. doi: 10.2169/internalmedicine.37.197.

Authors

H Tohgi¹, H Takahashi, K Utsugisawa, K Sasaki

Affiliation

¹ The Department of Neurology, Iwate Medical University, Uchimaru, Morioka.

PMID: 9550608
DOI: 10.2169/internalmedicine.37.197

No abstract available

Publication types

Review

MeSH terms

Atrial Fibrillation / complications
Brain Ischemia / complications
Brain Ischemia / drug therapy*
Brain Ischemia / prevention & control
Fibrinolytic Agents / therapeutic use*
Humans
Intracranial Embolism and Thrombosis / complications
Intracranial Embolism and Thrombosis / drug therapy
Intracranial Embolism and Thrombosis / prevention & control
Platelet Aggregation Inhibitors / therapeutic use
Recurrence
Thromboplastin / genetics
Thromboplastin / metabolism
von Willebrand Factor / genetics
von Willebrand Factor / metabolism

Substances

Fibrinolytic Agents
Platelet Aggregation Inhibitors
von Willebrand Factor
Thromboplastin